Product Information

OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2055 per EA under NDC 33342017510. Its NADAC has been published 124 times since Jul 3, 2024.

FDA first approved this application on Jun 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB

OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE
$0.2055per EA

Strength

25; 40 mg/1; mg/1

NDC

33342017510

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204801

FDA Approved

6/1/2023

TE Code

AB

On Market Since

6/2/2023

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has been published 124 times since Jul 3, 2024, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2055 per EA
All-time high$0.2457 (Jul 10, 2024)
All-time low$0.1789 (Nov 20, 2024)
52-week high$0.2343
52-week low$0.2023
Median price$0.2218
Average price$0.2200
Largest weekly change-24.5% (Nov 20, 2024)
Weeks tracked124
Tracking sinceJul 3, 2024

Price History

1W

0.0%

1M

-1.7%

3M

-7.2%

6M

-12.3%

1Y

-3.7%

3Y

N/A

5Y

N/A

All

-16.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.2055 per EA (NDC 33342017510), effective Nov 11, 2026.

How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has declined 16.3%. It has been tracked across 124 weekly CMS publications since Jul 3, 2024.

What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

Since Jul 3, 2024, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has ranged from a low of $0.1789 (Nov 20, 2024) to a high of $0.2457 (Jul 10, 2024), with a median of $0.2218 per EA.

Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB (NDC 33342017510) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.